The binding of cpichlorohydrin, 1,2-dichloroethane, 1,2-dibromoethane, chlorobenzcne, bromobenzene, and benzcnc to nucleic acids and proteins of different murine organs was studied in in vivo and iii vitro systems. The extent of in vivo enzymatic activation of brominated compounds was higher than that of chlorinated chemicals. Aryl halides wcrc bound mainly to liver DNA whereas interaction of alkyl halides with DNA of liver, kidney, and lung gave rise to similar binding extent. In vitro activation of all chemicals was mediatcd by microsomal P-450-dependent mixed function oxidase system which is present in rat and mouse liver and, in smaller amount, in mouse lung. Activation of alkyl halides by liver cytosolic GSHtransferases even occurred. Thc rclative rcactivity of chemicals in vivo. expressed as Covalent Binding Index (CBI) to rat liver DNA, was: 1,2-dibromoethane > bromobenzene > 1,2-dichloroethanc > chlorobenzene > epichlorohydrin > benzene. On the whole, it agreed with it1 vitro activation of chemicals, with genotoxicity data from other short-term assays and also with oncogenicity ofbcnzene, epichlorohydnn, 1,2-dichloroethane, and 1,2-dibromoethane. CBI values of chlorobenzene and bromobenzene gave the first clear cvidencc of genotoxicity and of possible carcinogenicity of these two chemicals.
INTRODUC~ION
Many chemicals, which are widely produced and used for various purposes as pesticides, solvents, or intermediates (lo), bclong to the vast class of halocompounds. Most of them exert toxic actions not only in liver, but also in kidney, lung, and central nervous system ofanimals and man. However, these compounds need metabolic activation by microsoma1 cytochrome P-450-dependent mixed function oxidase system. The role of GSH conjugation is somewhat contradictory becausc it leads to detoxificant steps in the case of aryl compounds or to activating steps in the case of alkyl halides here considered..Some halocompounds had been proven to be genotoxic as well as carcinogenic (8) (9) (10) ; the oncogenicity of others is only suspected. The Covalent Binding Index (CBI) could be employed either as a short-term assay of carcinogenicity for suspected initiators because it correlates with the Oncogenic Potency Index (OPI) (16) , or in order to compare the initiating potency of different chemicals known to exert an oncogenic effect (1 3), even providing information about mechanism of action (initiation and promotion). In the present work, we aimed at comparing the interactions of some alkyl and aryl halides with nucleic acids it1 vho and in vilro under similar experimental conditions, in order to better correlate OPI and CBI and to test the genotoxicity of possible oncogenic haloderivatives of benzene, which are carcinogenic in both humans (1 1) and rodents (1 1, 15 kidneys, and lungs were removed and processed as described elsewhere (1, 2, 5, 7, 14) , in order to measure the specific activity of DNA, RNA, and proteins. In the case of alkyl halides, stomachs were removed and processed, and the intcraction of benzene with DNA of splcen and bone marrow (target organs of toxic action) was measured also.
In Vifro Studies. Microsomal and cytosolic fractions were extracted from livers, kidneys, lungs (and stomachs when studying interaction ofalkyl halides) of male Wistar rats (300 g) and BALB/c mice (24 g). Animals were pretrcated i.p. with phenobarbitone (PB) (100 mg/kg/day, dissolved in sterile 0.9% NaCl solution) during the two days prior to sacrifice and tissues were'stored as previously described (14) .
Standard incubation mixture consisted oE 2.5 pCi 14C-labeled chemical, 1.5 mg DNA, 2 mg microsoma1 protein plus 2 mg NADPH, or 6 mg cytosolic protein plus 9.2 mg GSH to a final volume of 3 ml of 0.08 hi potassium phosphate-5 mM MgCI, buffer, pH 7.7. Reactions were camed out in duplicate or triplicate at 37°C in air and in the dark through the time-period sufficient to obtain maximal binding (60-120 min for different tracers) (1, 2, 4, 5, 7, 14) . Blanks were performed either in the absence of enzymes and in the absence of cofactors. Isolation, purification, and labeling determination of exogenous DNA, of microsomal RNA and proteins, and of cytosolic proteins were carried out as described elsewhere (1 4).
RESULTS AND DISCUSSION
In vivo interaction of halocompounds with macromolecules of murine organs is shown in Figs, 1-3. It appears that aryl halides mainly bound to liver DNA whereas alkyl halides interacted with DNA of all other organs to a similar binding extent: this agrees with "at distance" oncogenic effects produced, e.g., by 1,2-dichloroethane (1 0). Moreover, the binding of benzene to spleen and bone marrow DNA was slightly higher or even equal to that measured in liver DNA (data not shown). The covalent binding to rat liver DNA, expressed as CBI and pmoVmol DNA phosphate, is also shown in Table  I , where OPI values of chemicals whose oncogenicity have bcen proven are reported. Besides the greater reactivity in binding DNA of alkyl or aryl bromides with respect to the related chlorides, Table  I shows that halobenzcnes, with unknown oncogenicity, are much more reactive (36-and 6-fold for bromo-and chlorobenzene, respectively), than their parental compound, benzene, which is oncogenic for 6 ) who considered a larger number of oncogenic chemicals. Data obtained on mouse parallel those found on rat (Figs. 1-3 and Table I ), with the exception of 1,2-dibromoethane which gave rise to smaller amounts ofDNA adducts than bromobenzene did. However, when mean values of rat and mousc DNA labelings are considered, the relative reactivity of benzene and of its haloderivatives is: benzene 1, chlorobenzcne 4, bromobenzenc 24. is mediated by liver microsomes and by liver cytosol (only in the case of alkyl halides). Even mouse lung microsomes are capable of bidactivating alkyl and aryl halides. The relative reactivity of chemicals with DNA in cell-free systems is: epichlorohydrin 1, benzene 1.3, chlorobenzene 2.1, bromobenzene 4.3, 1,2-dichIoroethane 22.8, 1,2-dibromoethane 29.0, when the mean maximal in vifro binding mediated by rat and mouse enzymes (microsomal system alone or microsomal plus cytosolic system) is considered. Moreover, from data not shown, PB enhanced microsomal or cytosolic activity by the following factors: 2 for benzene, chlorobenzene, and epichlorohydrin, 10 for 1,2-dibromoethane and 1,2-dichloroethane, and 23 for bromobenzene. Spleen microsomes were unable to mediate the interaction of benzene with DNA; the interaction of all chemicals with DNA, catalyzed by cytochrome P-450-dependent microsomal mixed function oxidase system, was suppressed by SKF 525-A. The overall pattern of interaction of chemicals with macromolecular constituents of subcellular fractions was similar to that of exogenous DNA except alkyl-or arylchlorides which were more reactive than the related bromides. The comparison of in vivo and in vifro binding to nucleic acids shows that some discrepancy exists. Nevertheless, activation of halocompounds takes place in liver via a common metabolic pathway (Fig. 7) leading to formation of electrophilic epoxide and radical intermediates. Formation of activated oxygen species and lipid peroxidation even occur; however, the covalent binding of electrophilic metabolites to nucleophilic sites of macromolecules is still considered to be the major mechanism of hepatotoxicity by halocompounds (6) . The sufficiently high stability of some reactive intermediates of halocompounds could allow "at distance" effects and partly explain the above-mentioned differences between in vivo and in vitro interactions.
Finally, good correlations exist among covalent interaction with DNA, induction of unscheduled DNA synthesis, mutagenicity on microorganisms and on human cells, and carcinogenicity (species and/or target organ susceptibility) of alkyl halides (1). On the contrary, this sort of correlation cannot be established in the case of aryl halides since there are no data from other types of short-term assay of carcinogenicity, or they arc inadequate. There are no reports on possible oncogenicity of these compounds. However, CBI values of bromo-and chlorobenzene, which represent the first clear evidence of genotoxicity exerted by these two chemicals, are typical, respectively, of moderate and weak carcinogens provided with initiating activity. These data, the suficiently proven carcinogenicity of the nonhalogenated parental compound, the weak initiator benzene, and the strong similarities in metabolic pathways of benzene and of the two haloderivatives here considered (3, 12, 19, 20) would suggest that long-term assays of carcinogenicity of bromo-and chlorobenzene are needed.
